Very foolish to buy individual stock. Even the experts cannot beat the average. Buy the index.https://terb.cc/vbulletin/showthrea...e-stock-market-meltdown&p=6651991#post6651991
If you read my post early this week I used AC as an example of a stock that would take a tumble during times like these. It's going to get worse for the airline industry worldwide and it's going to take time before they recover, going long it's prudent, bad news makes you money now.
VBB
Problem with Airline is: massive amounts of capital parked , storage and maint fees for said capital. No end in sight to shut down. When they are cleared to operate will anyone have any money to fly? BUT oil is cheap.American Airlines now selling $12.25 per share.
Buying the index, going long, is a long term bull market strategy, we are not in a bull market. It is also considered a safe given market risk, beta equals 1.0, don't keep your eggs in one basket mentality, but that applies to normal times which these are not.Very foolish to buy individual stock. Even the experts cannot beat the average. Buy the index.
I'm waiting for the S&P500 to hit 2000. The rally last week isn't going to last. All economic data have gotten worse and continue to every day.The time to buy is now.
We will get below 2000 again on the S&P. The numbers coming out of the US are going to be ugly for the next 2-3 weeks and I am pretty sure the Russians just sank the OPEC+ meeting that was scheduled for tomorrow. You can buy now and make money but there will be better prices ahead.Covid-19 has shut the world down different parts of the world for the last 4 - 16 weeks, That has to have some effect on the economy. There was already an expected recession which occurs every 8 - 9 years. Then we have to worry about the presidential election in the US.
*Tips hat* Thanks for the heads up on this one.Nottyboi,
There will likely be a treatment within the next two months. But FDA approval for a vaccine is estimated to be a much longer process.
Gilead Sciences (GILD - NASDAQ) has an anti-viral drug called Remdesivir that is being studied in five large clinical trials, two of which could read out results in early April. Up until now, Gilead has made it possible for patients who want the drug to get it through a process called “compassionate use.” To date, the company said, it has provided emergency access to several hundred patients in the United States, Europe, and Japan.
Remdesivir works by preventing the virus from replicating. It is delivered intraveneously. Watch for rush FDA approval sometime in April. Gilead is ramping up production all around the world and they will still be no where close to meeting demand.
Matt